Evidence map›Paper›PMID 27262435›Full record

ArticleRedox biology2016

Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration.

Bradley A Carlson, Ryuta Tobe, Elena Yefremova, Petra A Tsuji, Victoria J Hoffmann, Ulrich Schweizer, Vadim N Gladyshev, Dolph L Hatfield, Marcus Conrad

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 178 papers.

0numbers the graph read from it
0cells of the map it votes in
178citing papers in PubMed
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

178 citing papers in PubMed, 300 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. MAFLD: a ferroptotic disease.Trends in molecular medicine · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

118 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Bradley A CarlsonMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ryuta TobeMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Elena YefremovaHelmholtz Zentrum München, Institute for Developmental Genetics, Neuherberg, Germany.
Petra A TsujiDepartment of Biological Sciences, Towson University, Towson, MD, USA.
Victoria J HoffmannOffice of the Director Diagnostic and Research Services Branch, National Institutes of Health, Bethesda, MD, USA.
Ulrich SchweizerInstitut für Biochemie und Molekularbiologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Vadim N GladyshevDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Dolph L HatfieldMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: hatfield@mail.nih.gov.
Marcus ConradHelmholtz Zentrum München, Institute for Developmental Genetics, Neuherberg, Germany. Electronic address: marcus.conrad@helmholtz-muenchen.de.
Helmholtz Zentrum München · DENational Cancer Institute · USNational Institutes of Health · USHarvard University · USTowson University · USUniversity of Bonn · DE

Funding

Methionine sulfoxide reduction, selenium and agingR01AG021518 · NIA · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2003 to 2018
$5.0M
Mechanisms of lifespan controlDP1AG047745 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2013 to 2018
$4.4M
IDENTITY OF TERMINATOR AND SELENOCYSTEINE UGA CODONSR01GM061603 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2000 to 2016
$4.0M
Functions of thioredoxin reductases and their targetsR37GM065204 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2011 to 2020
$4.0M
Selenium in Health and its incorporation into Protein as SelenocysteineZIABC011620 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HATFIELD, DOLPH · 2015 to 2016
$587k
NIA NIH HHS DP1 AG047745NIA NIH HHS R01 AG021518NIGMS NIH HHS R01 GM061603NIGMS NIH HHS R37 GM065204
6 · The paper itself

Abstract

The selenoenzyme glutathione peroxidase 4 (Gpx4) is an essential mammalian glutathione peroxidase, which protects cells against detrimental lipid peroxidation and governs a novel form of regulated necrotic cell death, called ferroptosis. To study the relevance of Gpx4 and of another vitally important selenoprotein, cytosolic thioredoxin reductase (Txnrd1), for liver function, mice with conditional deletion of Gpx4 in hepatocytes were studied, along with those lacking Txnrd1 and selenocysteine (Sec) tRNA (Trsp) in hepatocytes. Unlike Txnrd1- and Trsp-deficient mice, Gpx4

Indexed as

Liver RegenerationAnimalsCell SurvivalFemaleGene Expression RegulationGenotypeGlutathioneGlutathione DisulfideGlutathione PeroxidaseHepatocytesLipid PeroxidationLiverMaleMiceMice, KnockoutNecrosisGlutathioneGlutathione DisulfideGlutathione Peroxidaseglutathione peroxidase 4, mouseNfe2l2 protein, mouseNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseVitamin EFerroptosisLipid peroxidationSelenoprotein

Identifiers

PMID27262435
PMCPMC4900515
OpenAlexW2408722709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.